Huawei has made a comeback in China and is hoping to bring that momentum to overseas markets where its business has been ...

The upward journey may continue if the bulls gain further strength in the upcoming sessions. Below are some trading ideas for ...

AI startup OpenEvidence is raising a fresh round of capital from Sequoia to scale its chatbot for doctors. The new $75 ...

Carvana shares dropped 10% in extended trading Wednesday, even as the used car retailer reported better-than-expected ...

OpenAI now has 400 million weekly active users, up from 300 million in early December, OpenAI’s chief operating officer, Brad ...

Real-time index price for TSX Industrials EW Index (TXIE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Indian benchmark indices ended in the red on Friday, extending their losing streak to a third consecutive week. The decline ...

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks & Erratic Stock Market Performance. In this article, we are going to take a look at where Celanese Corporation (NYSE:CE) stands ...

DeepSeek founder Liang has received the lion’s share of media attention in recent weeks as his AI assistant ascended to the ...

The live streaming market size is expected to increase by US$20.64 billion, reflecting a CAGR of ~16.6% over 2024 and 2029, ...

The price of CVS stock has increased by 48.80% since Jim Cramer called the overall situation fraught. So, what happened?

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.